Justin J. McAnear, Chief Financial Officer at 10x Genomics, Inc. (TXG), sold 19,000 shares at $162.16 ($3.1M) on 2021-11-01, disclosed to the SEC on 2021-11-03.
Open-market sale of $3.1M TXG by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $160.48 | 300 | $48K | 1.5% |
| 2 | $162.16 | 500 | $81K | 2.6% |
| 3 | $163.34 | 4,667 | $762K | 24.5% |
| 4 | $163.34 | 4,667 | $762K | 24.5% |
| 5 | $164.05 | 4,333 | $711K | 22.9% |
| 6 | $164.05 | 4,333 |
| $711K |
| 22.9% |
| 7 | $164.96 | 200 | $33K | 1.1% |
| Total | $163.60 avg | 19,000 | $3.1M | 100% |
| Filing → |
| TXG | SELL | 2024-02-26 | $173K | — | Filing → |
| TXG | SELL | 2023-11-27 | $146K | — | Filing → |
| TXG | SELL | 2023-08-24 | $154K | — | Filing → |